The Lung Health Study
Currently Recruiting
Up to $3,500
Brisbane, Australia
This study is exploring a potential new therapy aimed at helping slow disease progression and improve outcomes for people living with idiopathic pulmonary fibrosis. This research is made possible with Healthy Volunteers.
Idiopathic pulmonary fibrosis, or IPF, is a long-term lung condition where the tissue in the lungs slowly becomes scarred and stiff.
Normally, your lungs are soft and stretchy, which makes it easy to breathe and for oxygen to pass into your blood. With IPF, scar tissue builds up in the lungs over time, making them thicker and harder. As this scarring increases, it becomes more difficult to breathe and harder for the body to get the oxygen it needs.
The purpose of this study is to evaluate how the experimental drug is processed in the body and to assess potential interactions between the study drug and medications currently approved for idiopathic pulmonary fibrosis (IPF).
What to expect
- Particpation in a monitored clinical environment.
- Study visits scheduled
- Support from a professional medical team
- Reimbursement for your time and commitment
Trial details
Study duration
- 5 nights stay
- 1 follow-up visit
The start date of this study is flexible. If you pass the initial screening, the study coordinator will arrange the exact study dates with you.
Study medication
Administered via oral tablets.
Additional eligibility
- Weight above 50kg
Ethics
An independent ethics committee has approved this clinical trial.
Are you a match?
Age
26 - 65 years old
Remuneration
Up to $3,500 *with screening reimbursement. Please see T&Cs.
Gender
Male or Female (Post-menopausal)
BMI
BMI 18 - 32 kg/m2
Commitment
5 nights, 1 clinic visit
Medical condition
Not taking any medications